Mr. Giannasi takes over the role from Amy Amick, who is moving to the company’s board of directors, according to a Nov. 12 Aspirion news release. Ms. Amick had served as Aspirion’s CEO since April 2023.
Mr. Giannasi has been an Aspirion board member since August 2022. His past experience includes serving as head of demand-side product for Datavant and chief product officer of Ciox.
He also previously served as executive vice president, chief AI officer, and chief data officer at Change Healthcare, where he implemented the company’s AI strategy while overseeing enterprise-wide data management. He also served as vice president of life sciences product strategy at Oracle.
“Nick embodies the requisite strategic vision to guide Aspirion forward in this rapidly evolving payer-provider landscape,” Aspirion’s board said in the release. “His proven success in merging clinical expertise with AI and technology positions him uniquely to address the RCM industry’s evolving demands.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
